Publisher: Taylor & Francis Ltd
ISSN: 1054-3406
Source: Journal of Biopharmaceutical Statistics, Vol.24, Iss.3, 2014-05, pp. : 660-684
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 3, 2011-05 ,pp. :
High-dose aspirin appears to be associated with a high rate of haemorrhagic events
Inpharma, Vol. 1, Iss. 1509, 2005-01 ,pp. :
Phase I oncology trials: risks and benefits vary by trial type
Reactions Weekly, Vol. 1, Iss. 1042, 2005-01 ,pp. :
Phase I oncology trials: risks and benefits vary by trial type
Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. :